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Allergen exposure may induce changes in the brainstem secondary neurons, with neural sensitization of the nucleus solitary tract
(NTS), which in turn can be considered one of the causes of the airway hyperresponsiveness, a characteristic feature of asthma.
We evaluated neurofunctional, morphological, and biochemical changes in the NTS of naive or sensitized rats. To evaluate the cell
firing activity of NTS, in vivo electrophysiological experiments were performed before and after capsaicin challenge in sensitized
or naive rats. Immunohistochemical studies, endocannabinoid, and palmitoylethanolamide quantification in the NTS were also
performed. This study provides evidence that allergen sensitization in the NTS induced: (1) increase in the neural firing response
to intratracheal capsaicin application, (2) increase of endocannabinoid anandamide and palmitoylethanolamide, a reduction of
2-arachidonoylglycerol levels in the NTS, (3) glial cell activation, and (4) prevention by a Group III metabotropic glutamate
receptor activation of neural firing response to intratracheal application of capsaicin in both näıve and sensitized rats. Therefore,
normalization of ovalbumin-inducedNTS neural sensitization could open up the prospect of new treatments based on the recovery
of specific brain nuclei function and for extensive studies on acute or long-term efficacy of selective mGlu ligand, in models of
bronchial hyperreactivity.
1. Introduction
Bronchial hyperresponsiveness (BHR), a characteristic fea-
ture of asthma, may be exacerbated by various local inflam-
matory mediators released by repeated exposures to allergen
[1, 2]. Over the last few years, it has been shown that
several inflammation-generated mediators induce long-term
functional modifications of the sensory airway neural path-
ways in rodent and primate models of asthma: neuroplastic
changes in the peripheral airway afferent nerves as well as
in the brainstem secondary neurons and/or motor vagus
output neurons have been demonstrated [3]. The direct
consequence of neuroplasticity in the brainstem nucleus of
solitary tract (NTS) or the dorsal motor nucleus of vagus
is mainly represented by neural sensitization which in turn
may be considered one of the causes of the BHR to various
bronchoconstrictor stimuli [4].
Over the last decade, evidence has accumulated on the
complex biomolecular mechanisms related to neural sen-
sitization and plasticity, which are critical for a variety of
phenotypic changes in neuron activities [5].These functional
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changes are considered to be at the basis both of several
physiological events such as memory and learning [5, 6]
and of many pathological conditions, such as chronic pain
syndromes [7]. Indeed, enduring neuropathic or inflamma-
tory pain is a well-characterized pathophysiological con-
dition in which a direct parallel between persistent expo-
sure to excitatory/inflammatory neurotransmitters and the
increased excitability of spinal post-synaptic neurons has
been clearly shown [8–11]. Many studies have proposed an
analogy between airway hyperresponsiveness and hyperalge-
sia. Considering that the endovanilloid oleoylethanolamide
excites sensory vagal neurons via TRPV1 receptors [12] and
that BHR mediated by several stimuli [13, 14] is abolished
following chronic treatment with capsaicin; sensory nerves
can represent a common pathway by which many stimuli can
induce BHR.These studies are consistent with the hypothesis
that “sensitization” of airway sensory nerves may contribute
toward this phenomenon [15].
Further confirmation of a similarity between the neural
adaptive mechanisms for airway neural sensitization and the
establishment chronic pain is the fact that both phenom-
ena share the same neurotransmitters and neuromodulators
(i.e., glutamate, SP, GABA, endocannabinoids, etc.) at both
peripheral (lung and trachea) and brainstem levels [3, 16,
17]. In particular, the endocannabinoids anandamide and
2-arachidonoylglycerol (2-AG) and their main cannabinoid
CB1 and CB2 receptors have been identified in the NTS [18],
where another molecular target of anandamide, the transient
receptor potential vanilloid type-1 (TRPV1) channel, is also
abundantly coexpressed with CB1 receptors [17].
Moreover, the anandamide congener palmitoylethanola-
mide (PEA), which activates peroxisome proliferator-activat-
ed receptor (PPAR)-𝛼, can also enhance anandamide actions
at CB1 and TRPV1 receptors [19]. Importantly, NTS TRPV1
channel stimulation by capsaicin was shown to induce the
cough reflex in the guinea pig [20], whereas CB1 receptors
in this nucleus seem to be more involved in the control
of emesis, oesophageal sphincter relaxation, and baroreflex-
evoked sympathoinhibition [17, 18, 21, 22].
Based on these considerations, we have evaluated some
functional, morphological, and biochemical changes occur-
ring in the NTS following airway sensory nerve activa-
tion in naive and ovalbumin-sensitized rats. In particular,
we evaluated (i) the responsiveness of the intrinsic NTS
neurons by intratracheal application of capsaicin; (ii) the
levels of the two major endocannabinoids, anandamide, and
2-AG and of the cannabinoid receptor-inactive PEA; (iii)
the morphological changes in NTS microglia and astroglia.
Group III metabotropic glutamate receptors include mGlu4,
mGlu6, mGlu7, and mGlu8 mainly located on presynaptic
terminals where they modulate neurotransmitter release. L-
(+)-2-amino-4-phosphonobutyric acid (L-AP4), L-serine-O-
phosphate (L-SOP), and (1S, 2R)-1-amino-phosphonometh-
ylcyclopropane carboxylic acid (1S, 2R)-APCP are broad
spectrum agonists whereas L-AP4 and L-SOP 𝛼-methyl
analogs, (S)-𝛼-methyl-2-amino-4-phosphonobutanoic acid
(MAP4), and (RS)-𝛼-methylserine-O-phosphate (MSOP)
behave as antagonists. Since group III mGlu receptor mod-
ulate local neurokinins and glutamate releases [23], we also
analyzed their roles in NTS neuron activities before and after
capsaicin-induced C-fibers afferent nerve activation.
2. Materials and Methods
2.1. Animals. Male Norway brown rats (250–300 g) were
housed 3 per cage under controlled illumination (12 : 12 h
light : dark cycle; light on 06.00 h) and environmental condi-
tions (ambient temperature 20–22∘C, humidity 55–60%) for
at least 1 week before the commencement of experiments.
Rat chow and tap water were available ad libitum. The
experimental procedureswere approved by theAnimal Ethics
Committee of the Second University of Naples. Animal care
was in compliance with Italian (D.L. 116/92) and EEC (O.J.
of E.C. L358/1 18/12/86) regulations on the protection of
laboratory animals. All efforts weremade tominimise animal
suffering and to reduce the number of animals used.
2.2. Sensitization. The rats were sensitized by a subcutaneous
(sc) injection of 0,66mL of a suspension of 1mg OVA
plus 300mg of aluminium hydroxide in 0,9% NaCl solution
(saline) [24]. Näıve rats received saline only.This was consid-
ered Day 1 of sensitization. Seven days after sensitization, the
animals were boosted subcutaneously (sc) with an identical
injection of ova suspension. Twenty one days after the initial
injection, animals were challenged with 5% aerosolized OVA.
OVA was aerosolized for 5min using an ultrasonic nebuliser
and nebuliser control unit (Buxco Electronics). On the day
22, 24 hours after the OVA challenge, bronchopulmonary
function was performed. Control animals were challenged
with 0.9% saline solution. To evaluate the successful of OVA
sensitization, five rats of each group (sensitized and naive)
were used to assess airway responsiveness. Animal were
anaesthetized by an i.p. injection of urethane (1.3 g/kg, i.p.)
and lung function was assessed 30min later. The anaes-
thetized rats were exposed to sterile saline for 2min and
lung functions were recorded. Airway responsiveness (𝑅
𝐿
)
was measured following aerosol administration of double
concentrations of metacholine for 30 s and measurements of
respiratory parameters were taken every minute for 5min.
Peak value of 𝑅
𝐿
was measured after each concentration and
the challenge was stopped at 128mg/mL metacholine. We
have measured the concentrations of metacholine inducing
200% increase of 𝑅
𝐿





2.3. Experimental Protocol. Groups of 5 animals per treat-
ment were used with each animal being used for one treat-
ment only.
A group of naive rats was implanted with guide cannulae
and received an intracerebral microinjection of 2 microliters
of ACSF and served as a control of the intracerebral drug
microinjection.
For the in vivo extracellular recording, naive and sensi-
tized rats were grouped as follows.
(a) Groups of naive or sensitized rats received intracere-
bral administration of L-AP4 (2 and 4 nmol/rat) alone
or L-AP4 (4 nmol/rat) in combination with MSOP
(100 nmol/rat). When L-AP4 was administered in
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combination with MSOP, the latter was centrally
delivered 5min before the administration of L-AP4.
(b) Groups of naive or sensitized rats received intracere-
bral administration of MSOP (100 and 300 nmol).
All groups received intratracheal capsaicin challenge (300 pg
in 20𝜇L) or respective vehicle. In a separate set of experi-
ments, groups of sensitized and naive rats were killed with a
lethal dose of pentobarbital and decapitated for assay of endo-
cannabinoid content and for the immunohistochemistry
analysis in the NTS area. The doses were chosen according
to previous data [25].
2.4. Preliminary Surgical Preparations. Each rat was anaes-
thetized with an i.p. injection of pentobarbital (50mg/kg).
A catheter was introduced into the jugular vein for admin-
istering saline or for the continuous infusion of propofol (5–
10mg/kg/h) to maintain a constant anaesthesia. Trachea was
cannulated below the larynx, and a tiny catheter was also
connected to a side-part of that cannula to allow intratracheal
vehicle or capsaicin (300 pg in 20𝜇L) application. The cervi-
cal vagus nerve ipsilateral to the recording site was isolated
(mainly the right side) for the placement of the stimulating
electrode. In order to perform administrations of drug or
respective vehicle (artificial cerebrospinal fluid, ACSF, com-





into the cerebral lateral ventricle, a 23-gauge, 12mm-long
stainless steel guide cannula was stereotaxically lowered until
its tip was 1.5mm above the ventricle by applying coordinates
from the atlas of Paxinos and Watson [26] (A: 0.92mm and
L: 1.5mm from bregma, V: 2.9mm below the dura).
These coordinates were chosen in order to have enough
space to allow stereotaxic manipulation for the positioning of
both the guide cannula for drug microinjection and of the
tungsten electrode for the in vivo NTS cell recording. The
guide cannula was anchored with dental cement to a stainless
steel screw in the skull. We used a David Kopf stereotaxic
apparatus (David Kopf Instruments, Tujunga, CA, USA) with
the animal positioned on a homeothermic temperature con-
trol blanket (Harvard Apparatus Limited, Edenbridge, Kent).
The guide cannula for drug microinjection was implanted on
the same day as the electrophysiological recording. Direct
intracerebral administration of drugs or respective vehicle
was conducted with a stainless steel cannula connected by
a polyethylene tube to a SGE 1-microlitre 26-gauge syringe,
inserted through the guide cannula and extended 1.5mm
beyond the tip of the guide cannula to reach the cerebral
ventricle. Volumes of 2 𝜇L drug solutions or vehicle were
injected into the ventricle over a period of 60 s and the
injection cannula gently removed 2min later.
2.5. NTS Extracellular Recording. After implantation of the
guide cannula into the cerebral ventricle, a tungsten micro-
electrode was stereotaxically [26] lowered through a small
craniotomy to record the activity of the airway-related NTS
neurons before and after intratracheal application of cap-
saicin.These neuronswere identified by stimulating the vagus
nerve (200–600𝜇A, 0.5–0.8ms pulses) at 1 Hz during the
slow (1𝜇ms) electrode lowering within the NTS [14, 27].
Extracellular single-unit recordings were made in the NTS
with glass insulated tungsten filament electrodes (3–5MΩ)
(FHC Frederick Haer & Co., ME, USA) using the follow-
ing stereotaxic coordinates: 3–3.6mm caudal to lambda, 1–
1.5mm lateral, and 7.7–8.1mm depth from the surface of the
brain [26].The recorded signals were amplified and displayed
on analog and digital storage oscilloscope to ensure that the
unit under study was unambiguously discriminated through-
out the experiment. Signals were also fed into a window
discriminator, whose output was processed by an interface
(CED 1401) (Cambridge Electronic Design Ltd., UK) con-
nected to a Pentium III PC. Spike2 software (CED, version
4) was used to create peristimulus rate histograms online
and to store and analyse digital records of single-unit activity
offline. Configuration, shape, and height of the recorded
action potentials were monitored and recorded continuously,
using a window discriminator and Spike2 software for on-
line and off-line analysis. Once an NTS unit was identified
from its background and tracheal/vagus stimulation activity,
we optimised spike size before all treatments. This study
only included neurons whose spike configuration remained
constant and could clearly be discriminated from activity in
the background throughout the experiment, indicating that
the activity from one neuron only and from that same neuron
wasmeasured. Only one neuron was recorded in each rat and
the recording RVM site was marked with a 20𝜇ADC current
for 20 s.
2.6. Endocannabinoid Extraction and Quantification
2.6.1. Analysis of Endocannabinoid Contents. Anaesthetized
rats were decapitated and their brains were rapidly removed
and immersed in oxygenated ice-cold artificial cerebrospinal
fluid. A block of tissue containing the NTS was cut using a
vibrotome (Vibratome 1500, Warner Instruments, CT, USA).
A brainstem slice of 2–2.5mm was cut throughout the
medulla containing the NTS region and using the following
stereotaxic coordinates: 3–3.6mm caudal and 1–1.5mm lat-
eral to lambda [26]; the right and left NTS from the same
rat were isolated under microscope (M650, Wild Heerbrugg,
Switzerland) and pooled. Tissues were homogenized in 5 vol
of chloroform/methanol/Tris HCl 50mM (2 : 1 : 1) contain-







-2-AG. Deuterated standards were synthesized from
d
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-palmitic acid and ethanolamine.
Homogenates were centrifuged at 13,000 g for 16min (4∘C),
the acqueous phase plus debris were collected and extracted
again twice with 1 vol of chloroform.The organic phases from
the three extractions were pooled and the organic solvents
evaporated in a rotating evaporator. Lyophilized sampleswere
then stored frozen at −80∘C under nitrogen atmosphere until
analyzed and were resuspended in chloroform/methanol
99 : 1 by vol. The solutions were then purified by open bed
chromatography on silica as described by Maione et al. [28].
Fractions eluted with chloroform/methanol 9 : 1 by vol. (con-
taining anandamide, pamitoylethanolamide, and 2 AG) were
collected and the excess solvent evaporated with a rotating
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evaporator, and aliquots analyzed by isotope dilution-liq-
uid chromatography/atmospheric pressure chemical ionisa-
tion/mass spectrometry (LC APCI-MS) carried out under
conditions described previously [28] and allowing the sep-
arations of 2-AG, palmitoylethanolamide, and anandamide.
MS detection was carried out in the selected ion monitoring
mode using m/z values of 356 and 348 (molecular ion+1
for deuterated and undeuterated anandamide), 304.0 and
300.0 (molecular ion+1 for deuterated and undeuterated
palmitoylethanolamide), and 384.35 and 379.35 (molecular
ion+1 for deuterated and undeuterated 2 AG). The area
ratios between signals of deuterated and undeuterated anan-
damide varied linearly with varying amounts of undeuterated
compounds. Anandamide, palmitoylethanolamide, and 2AG
levels in unknown samples were therefore calculated on the
basis of their area ratios with the internal deuterated standard
signal areas.
2.7. Immunohistochemistry . Under pentobarbital anaesthesia
animals were transcardially perfused with 0.9% saline solu-
tion followed by 4% paraformaldehyde in 0.1M phosphate
buffer. The brain was excised, postfixed for 4 hr in the per-
fusion fixative, cryoprotected for 72 h in 20% sucrose in
0.1M phosphate buffer, and frozen in O.C.T embedding
compound. 20𝜇m transverse sections were cryostat cut and
thaw-mounted onto glass slides. The NTS was identified
based on the Paxinos and Watson Atlas coordinates (1986)
[26]. Slides were incubated overnight with primary antibody
solutions for the microglial cell marker Iba-1 (Rabbit anti-
ionized calcium binding adapter molecule 1; 1 : 1000; Wako
Chemicals, Germany), the astrocytes marker GFAP (Glial
fibrillary acidic protein; 1 : 1000; DAKO, USA). Following
incubation sections were washed and incubated for 3 hr
with secondary antibody solution (goat anti-rabbit, IgG-
conjugatedAlexa Fluor 488; 1 : 1000;Molecular Probes, USA).
Slides were washed, cover-slippedwithVectashieldmounting
medium (Vector Laboratories, USA), and visualised under a
Zeiss Axioplan 2 fluorescent microscope.
Quantitative assessment was carried out by determining
the intensity of positive profiles for eachmarker within a fixed
area of the NTS. A box measuring 104 𝜇m2 was placed onto
areas of the lateral, central, and medial NTS and the intensity
of positive profiles within this area recorded by a AxioVision
Rel. 4.6 program.Thismeasurement protocol was carried out
on three NTS sections from each animal.
2.8. Drugs. Capsaicin (Sigma-Aldrich, Milano Italy) was dis-
solved in a solution consisting of ethanol and water (6 : 4).
L-2-Amino-4-phosphonobutyric acid and (RS)-𝛼-meth-
ylserineo-phosphate were purchased by Tocris Bioscience,
Bristol, UK, and dissolved in ACSF.
2.9. Statistics. For electrophysiological study, the single extra-
cellular recording (action potentials) was analysed offline
from peristimulus rate histograms using Spike2 software
(CED, version 4). The neuron responses, before and after
capsaicin-induce stimulation or following intracerebroven-




















Sensitized rats Control rats
Figure 1: Airway responsiveness to methacholine in ovalbumin
(sensitized) or saline treated rats (control) (𝑛 = 5). ∗∗𝑃 < 0.01
compared with control group. Circles represent single values and
squares represent mean values.
expressed as spikes/sec (Hz). In particular, basal values were
obtained by averaging the activities recorded 10min before
drug applications. Data are presented as mean ± standard
error (S.E.) of changes in neuron responses (extracellular
recordings).
Statistical comparisons of values from different treated
groups of rats were made using the two-way analysis of vari-
ance (ANOVA) for repeated measures followed by the Tuk-
ey/Kramer test for post hoc comparisons. Comparisons
between pre- and posttreatment ongoing activity and cap-
saicin-related cell burst were performed by applying the
nonparametric Wilcoxon matched-pairs signed rank test.
Mean values for each group were then compared using
Student’s t-test. 𝑃 < 0.05 was set as the level of statistical
significance.
The amounts of endocannabinoids were expressed as pi-
comoles or nanomoles per gram of wet tissue extracted and
were compared by ANOVA followed by Bonferroni’s test.
3. Results
3.1. Airway Responsiveness and Endocannabinoid Levels Mea-
surements of Naive and Sensitized Rats. Baseline absolute
value of 𝑅
𝐿
and 𝐶dyn was not significantly different between
two groups.
In sensitized rats, OVA aerosol caused an acute bron-
choconstriction, with an approximately threefold greater
increase in 𝑅
𝐿
and decrease in 𝐶dyn respect to an aerosol of
saline solution (data not shown). OVA challenge exposure
resulted in an increase of airway responsiveness to inhaled
histamine, approximately fourfold (𝑃 < 0.01) when com-
pared with saline challenge (PC
100
: 69mg/mL; 18mg/mL
saline and ova groups, resp.) (Figure 1). Moreover, sensitiza-
tion caused an enhancement of the endogenous TRPV1/CB1
“hydrid” agonist, anandamide, and of the endogenous PPAR𝛼
agonist palmitoylethanolamide levels in the NTS area, whilst
lowering the levels of the CB1-selective endocannabinoid 2-
AG (Table 1).



























Figure 2: Example of ratemeter records which illustrate the spontaneous activity of NTS neurons before and after capsaicin administration
(hollow arrow). (a) control rat, (b) ovalbumin-sensitized rat. A single oscilloscope trace (2min recording) shows spontaneous activity of a
single unit (long black arrow) immediately before and after intratracheal capsaicin application. Small black arrowheads indicate single vagal
stimulations. Scale bar = 1min.
Table 1: Endocannabinoid levels in the NTS area.
NTS
Control Sensitized
Anandamide (pmol/g) 32.0 ± 3.0 49.9 ± 3.1∗
2-AG (nmol/g) 7.4 ± 0.1 6.5 ± 0.1∗
Palmitoylethanolamide (pmol/g) 961.4 ± 16.4 1187.8 ± 43.4∗
Data are means ± SEM of 𝑛 = 4 separate experiments. ∗𝑃 < 0.05 as assessed
by ANOVA followed by Bonferroni’s test.
3.2. The Effect of Intratracheal Capsaicin on Airway-Related
NTS Neuron Activities in Naive or Sensitized Rats. The results
are based on airway-related NTS neurons (group size =
5; one cell recorded from each animal per treatment) at
a depth of 7.7–8.1𝜇m from the surface of the brain, the
estimated location of the neurons being within the NTS.
All recorded neurons showed very little spontaneous activity
(they frequently paused completely during 20–50 s) and
dischargedwith amean frequency of 0.7±0.03 spikes/s.These
neurons were identified by an increased burst of activity just
after vagus nerve stimulation (Figure 2).
Intratracheal application of capsaicin (300 pg in in 20 𝜇L)
induced an increase in the firing activity of the airway-
related NTS neurons in naive rats, which was maximal (9.9 ±
0.7 spikes/s) 20min after the administration of capsaicin
(Figure 2(a)). In sensitized rats, intratracheal application of
capsaicin induced a higher increase in the firing activities
(12.4±0.6 spikes/s) of the airway-relatedNTS neurons than it
did in naive rats. Unlike the naive rats, we did not observe any
recovery in the sensitized rats during the observation period
(60min post-capsaicin) (Figure 2(b)).
3.3. The Effect of L-AP4 on Capsaicin-Induced Change on the
Airway-Related NTSNeuron Activities in Naive and Sensitized
Rats. Intracerebroventricular microinjections of L-AP4 (2–
4 nmol/rat) did not induce any effect on the basal value of
airway-related NTS cells ongoing activities (data not shown).
The highest doses of L-AP4 (4 nmol/rat) prevented the
capsaicin-induced increase in the airway-relatedNTS neuron
activities in both naive and sensitized rats (Figures 3(a) and
3(b)). The effects of L-AP4 (4 nmol/rat) were prevented by
pretreatment withMSOP (100 nmol/rat), which per se did not
significantly change the airway-related NTS neuron (Figures
3(a) and 3(b)).
3.4. Immunohistochemistry. Immunoreactivity (IR) for the
microglial cell marker Iba-1 was observed in the NTS of
control and sensitized animals. In sensitized animals, the
increased expression of Iba-1 and specific morphological
changes, such as the increased thickness of cell bodies and
process retraction, suggest activation of microglia. In partic-
ular, quantitative analysis of Iba-1 IR revealed a significant
increase in the intensity of Iba-1 positive cells in the NTS of
sensitized rats (79.9 ± 4.6 arbitrary units), in comparison to
naive animals (58.9±3.8 arbitrary units). As far as the analysis
of astrocyte activity is concerned, IR for marker GFAP was
evaluated in the NTS of control and sensitized animals. In
sensitized animals, we observed an increased expression of
GFAP and specific morphological changes, such as increased
astrocyte cell body and process thickness, assuming reactive
astrogliosis following sensitization to ovalbumin. In partic-
ular, GFAP IR quantitative analysis revealed a significant
increase in the intensity of GFAP positive cells in the NTS
of sensitized rats (147.1 ± 3.8 arbitrary units), in comparison
to control animals (101.6 ± 3.3 arbitrary units) (Figure 4).
4. Discussion
This study shows that ovalbumin-induced sensitization
increases: (1) the NTS neural firing response to intratracheal
capsaicin application, (2) the endocannabinoid anandamide
level, and (3) astro- and microgliosis in the NTS. Moreover,
we also show that the intracerebroventricular application of a
Group III metabotropic glutamate receptor agonist prevents
the neural firing response to the intratracheal application
of capsaicin in both näıve and sensitized rats. The overall
hypothesis linking these different findings to the generation
of bronchial hyperresponsiveness (BHR) is based on the
possibility that peripheral nerve sensitization such as, for
example, during persistent inflammation, may induce long-
lasting pathophysiological modifications in the NTS neural
and glial cell functioning. Indeed, in a similar way to the
changes observed in the spinal cord in chronic pain [7, 9], we
suggest that, also in this case, a higher discharge of the afferent
sensitized neurons may increase the release of excitatory
neurotransmitters (i.e., glutamate and CGRP) in the NTS
responsible for neurons, astrocytes, and microglia pheno-
typic modifications [29]. Importantly, pathophysiological
conditions like chronic pain or inflammation are associated
with alterations in the levels of some on-demand produced
endocannabinoid/endovanilloids such as anandamide, PEA,
or 12-lipoxygenase products (i.e., 12-HPETE) [30–33].
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(b)
Figure 3: Effect of vehicle (20% DMSO in ACSF) or capsaicin (300 pg in 20𝜇L) in näıve (a) and sensitized (b) rats. L-AP4 (4 nmol/rat)
(hollow arrow) prevented the capsaicin (full arrow) induced increase in the airway-related NTS neuron ongoing activities. This effect of L-
AP4 (4 nmol/rat) was prevented by pretreatment withMSOP (100 nmol/rat) (arrow with lines). Each point represents the mean± SEM of five
































(f) (g) (h) (i)
(l) (m) (n) (o)
Figure 4: (a) Low magnification of NTS brain area and schematic representation (see Paxinos and Watson, 1986 [26]) of the area beside. (b,
f, l) Iba-1 IR in NTS of a naive rat. (c, g, m) Iba-1 IR in NTS of sensitized rat to ovalbumin. (d, h, n) GFAP IR in NTS of a naive rat. (e, i, o)
GFAP IR in NTS of sensitized rat. High magnification of Iba-1 + profiles (l, m) and GFAP + profiles (n, o) arrows. Scale bars = 100 𝜇m. (A, B)
Quantitative analysis of Iba1 and GFAP staining in NTS reveals significantly increased numbers of Iba-1 and GFAP-positive cells in the NTS
after ovalbumin sensitization. Data represented as mean ± SEM, 𝑛 = 3 rats per group. ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001 compared to control group,
one-way ANOVA, post hoc Tukey.
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Consistently with this possibility, the increase in the
NTS neural firing response to intratracheal application of
capsaicin in sensitized animals has led us to believe that these
cells might be hyperactive airway-activated NTS neurons
[34]. Considering that in this study intratracheal capsaicin
induced a higher and long-lasting firing discharge of the
airway-related NTS neurons, one might speculate that sim-
ilarly to previous findings [35–37], chronic allergen challenge
can lead to persistent inflammation and activation of afferent
vagal fibers modulating the activity of the airway-activated
NTS neurons. Indeed, persistent stimulation on the small-
diameter nerve fibers (i.e., C-fibers and A𝛿-fibers) by several
direct and indirect acting chemical mediators in the lung
may be responsible for afferent neuron sensitization and for
phenotypic modifications in NTS cell functioning [29]. In
line with this study, NTS neural sensitization in slices of
asthmatic primates was shown by Chen and colleagues [38],
and it may be possible that the electrophysiological effects
observed here could also be related to the increased activity
of microglia and astrocytes in the NTS that, in turn, can alter
the synaptic plasticity. Accordingly, with the idea that glia
plays critical role in determining or sensing neuronal well-
being and is capable of shaping neural activities either in
healthy or in several pathological brain conditions [39–41],
our current findings demonstrate the occurrence of gliosis
in the NTS of albumin-sensitized rats. However, it is also
intriguing that in many cases gliosis has two faces, protective
or deleterious, and understanding of the rules governing this
duality is still in its initial stages [42]. Nevertheless, there is
evidence to suggest that neurons and gliamutually affect their
functioning through complex, not fully exploredmechanisms
[39, 43] generating alterations in the levels of excitatory (i.e.,
glutamate and CGRP) and inhibitory (i.e., GABA and endo-
cannabinoids) neurotransmitters. In particular, the recently
identified endovanilloids/endocannabinoids are capable of
glia activation/differentiation and play roles in neurodegen-
erative disorders accompanied by microglial activation [44–
46]. Regarding endocannabinoid involvement in the modu-
lation of the NTS neural activities, it has been shown that,
by acting on presynaptic cannabinoid CB1 receptors, they
inhibit both excitatory and inhibitory signalling in the NTS
[47]. In contrast, by activating TRPV1 receptors, the endo-
cannabinoid anandamide stimulates glutamatergic signalling
[48], with subsequent (1) stimulation of GABA release in this
nucleus and a subsequent decrease in NTS neuronal firing
[48]; and/or (2) stimulation of output neurons; two effects
that would reduce and increase bronchoconstriction (in the
latter case via reflex output disinhibition and increased bron-
choconstrictive reflexes), respectively. However, the effect of
CB1 receptor activation has so far mostly been related to
the control of emesis, lower visceral functions, and blood
pressure [17, 18, 21, 22].
In order to preliminarily evaluate a role of the endo-
cannabinoid system at NTS level, we measured the content of
the twomore representative endocannabinoids, anandamide,
and 2-AG, as well as of the PPAR-𝛼 endogenous agonist
that also enhances anandamide actions at CB1 and TRPV1
receptors, palmitoylethanolamide (PEA). Here, we show
that airway sensitization is accompanied by a statistically
significant enhancement of anandamide and PEA, whereas
it induced a reduction in 2-AG levels in the NTS. Although
endocannabinoids like anandamide might inhibit synaptic
transmission via CB1 receptors in the NTS [47], we found
that the overall endocannabinoid tone in this nucleus might
remain unchanged or have even decreased following airway
sensitisation, because of the opposite changes of anandamide
and 2-AG levels and the fact that basal 2-AG levels are
higher than AEA levels. Indeed, a reduction rather than an
increase in cannabinoid receptor activity would be more
in line with the increased microglial and glial cell density
observed here in the NTS following ovalbumin sensitisation,
since (1) CB1 receptor activation was recently shown to
inhibit gliosis induced by a 𝛽-amyloid peptide [49]; (2) both
CB1 and CB2 receptor activations were found to inhibit
the release of proliferation- and motility-inducing cytokines
from astrocytes [50]; and (3) CB2 receptor agonists inhibit
microglial cell activation in animal models of neuroinflam-
matory disorders [51, 52]. On the other hand, the elevated
levels of anandamide and PEA in the NTSmight underlie the
increased microglial density observed in this nucleus follow-
ing ovalbumin sensitisation, since these two neurotransmit-
ters synergistically stimulate microglial migration via non-
CB1 non-CB2 receptors [53]. Conversely, since microglial
cells producemore PEA and anandamide than 2-AG [54], the
observed changes inNTS levels of these compoundsmight be
due to the elevated activemicroglia found in sensitised rats. It
is worth noting that opposing regulation on anandamide and
2-AG levels is not unprecedented in literature, and a recent
finding indicates that, by activating TRPV1, anandamide
might in fact reduce 2-AG biosynthesis in the striatum [55,
56].
The above observations suggest that anandamide may
preferentially activate TRPV1 in the NTS than cannabi-
noid receptors, as has been observed in the periaqueductal
grey following administration of intermediate doses of an
inhibitor of anandamide enzymatic hydrolysis [28]. In the
presence of (1) concomitantly elevated levels of PEA, which
potentiates anandamide effects at TRPV1 [57], and is unlikely
to act via PPAR-𝛼 (which has never been described as
being expressed in the NTS), and (2) reduced CB1 tone,
which disinhibits TRPV1 activity [56], anandamide activity
at these channels might be enhanced further. The subse-
quent enhancement of glutamatergic signalling would either
stimulate NTS output neuron activity, thus contributing to
sensitisation-induced airway hyperresponsiveness. Alterna-
tively, it could enhance GABAergic signalling and hence
counteract NTS neuronal firing [48] and bronchoconstric-
tion, representing an adaptive response to sensitization. The
former possibility is supported by our finding that the block-
ade of glutamatergic signalling by Group III metabotropic
glutamate receptors activation reduces capsaicin-induced
elevation of NTS neuronal activity. However, since prolonged
activation of TRPV1 can also cause its desensitisation, it is
possible that ovalbumin-induced elevation of anandamide,
by desensitising TRPV1, acts in a similar way to Group III
mGlu receptor activation.
Indeed, vagal brainstem circuits seem to be organized
in such a way that Group II subtype receptors (mGlu2
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and mGlu3) are expressed on GABAergic and glutamatergic
intrinsic NTS neurons, whereas Group III mGlu receptors
seem to be mainly expressed on glutamatergic nerve termi-
nals impinging on output preganglionic neurons [23]. While
NMDA and AMPA/Kainate receptor contribute to the exci-
tatory inputs and in the activity-dependent plastic changes of
NTS during airway hyperreactivity [58, 59]. Group III mGlu
receptors have been shown to significantly contribute to the
depression of autonomic signal transmission by attenuating
the presynaptic release of glutamate and neurokinins [38]. In
this study, the intracerebroventricular administration of L-
AP4, the relative selective Group III metabotropic glutamate
receptor agonist, prevented the airway-related NTS neuron
discharges induced by intratracheal capsaicin in naı̈ve and
sensitized rats and confirming their modulatory role in
glutamate release. Moreover, it is worth noting that the
same dose of L-AP4 prevented capsaicin-induced NTS cell
discharges in both näıve and sensitized rats.This observation
allows us to speculate that the occurrence of desensitization
mechanisms for Group III mGlu receptors might be excluded
in the sensitization model applied here. If this may repre-
sent an additional advantage in the potential management
of bronchial hyperreactivity with selective mGlu receptor
ligands, it is obvious that extensive studies are needed in
order to examine their possible systemic use and efficacy in
different in vivo models of bronchial hyperresponsiveness or
asthma in more detail.
5. Conclusions
In conclusion, we found that the allergen sensitization in the
NTS induced (1) an increase in the neural firing response to
intratracheal capsaicin application, (2) an endocannabinoid
anandamide increase, and (3) glial cell activation. Although
the pathophysiological significance of these different findings
remains to be assessed, they could however be relevant to the
alteredNTS neurotransmitter and cellularmorphofunctional
changes, which in turn might be collectively involved in the
long-lasting NTS cell phenotypic modifications. The overall
hypothesis is that the different findings are not independent
events, but are direct consequence of the peripheral nerve
sensitizationwhich is in turn capable of inducing long-lasting
airway-related NTS neural sensitization and hence bronchial
hyperresponsiveness. Interestingly, it was also found that
acute intracerebroventricular application of a Group III
metabotropic glutamate receptor agonist prevented a neural
firing response to intratracheal application of capsaicin in
both näıve and sensitized rats. Normalization of ovalbumin-
induced NTS neural sensitization opens up the prospect of
new treatments based on the recovery of specific brain nuclei
function and for extensive studies to examine the acute or
long-term efficacy of selectivemGlu ligand in specificmodels
of bronchial hyperreactivity in greater detail.
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